Position in VKTX
as of Jun 30, 2026
· filed Jul 7, 2026
Position Value
$341,454
+$137,164 QoQ
Shares Held
8,753
+50.7% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#12
of 34 holders
Holding Since
Jun 2022
9 quarters on record
Voting authority
Sole 53.27316348680452.ToString("F0")%
Shared 0.ToString("F0")%
None 46.72683651319547.ToString("F0")%
Common Shares in VKTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026180 WEALTH ADVISORS, LLC holds $26,828,326 across 11 Biotechnology names. VKTX ranks #6 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MNKD |
Mannkind Corp
|
4,959,351 | $21,126,835 | |
| 2 | MRNA |
Moderna, Inc.
|
35,750 | $2,503,572 | |
| 3 | INCY |
Incyte Corp
|
7,045 | $798,621 | |
| 4 | RXRX |
Recursion Pharmaceuticals, Inc.
|
190,562 | $699,362 | |
| 5 | CRSP |
CRISPR Therapeutics AG
|
7,257 | $395,796 | |
| 6 | VKTX |
Viking Therapeutics, Inc.
This page
|
8,753 | $341,454 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
548 | $272,208 | |
| 8 | EXEL |
Exelixis, Inc.
|
4,266 | $232,113 |
All Filings in VKTX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $341,454 | 8,753 | Shares | Sole | 2026-07-07 | |
| 2025-12-31 | $204,290 | 5,807 | Shares | Sole | 2026-01-09 | |
| 2023-12-31 | $186,100 | 10,000 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $143,910 | 13,000 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $210,730 | 13,000 | Shares | Sole | 2023-07-12 | |
| 2023-03-31 | $233,100 | 14,000 | Shares | Sole | 2023-04-07 | |
| 2022-12-31 | $190,820 | 20,300 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $54,400 | 20,000 | Shares | Sole | 2022-10-12 | |
| 2022-06-30 | $49,130 | 17,000 | Shares | Sole | 2022-07-11 | |
| No filing history on record for this holder in this stock. | ||||||